• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS NEUROSTIMULATOR
Device Problem Insufficient Information (3190)
Patient Problems Cyst(s) (1800); Purulent Discharge (1812); Staphylococcus Aureus (2058)
Event Date 01/27/2015
Event Type  Injury  
Event Description
(b)(6) 2014 - subject underwent her third neurostimulator replacement procedure.The rns system consists of a neurostimulator, a connected depth lead (dl-330-10) and a cortical strip lead (cl-315-10).(b)(6) 2015 - subject noted a small depression in the area of the neurostimulator implant.It was initially tender to touch and cyst-like, then it "popped", releasing waxy material and now leaving a depression at the site of the previous cyst.The depression is still there and cultures positive for staph aureus.Antibiotic treatment was started.(b)(6) 2015 - the ferrule was replaced to allow treatment of the infection.In addition antibiotics were introduced into the incision site as an additional measure to treat the infection.The rns system remains implanted and both therapy and detection are enabled.
 
Manufacturer Narrative
(b)(4), this patient is part of the clinical trial.Udi - na.(b)(4) 2015 (b)(4) voided this complaint.There was no reported product malfunction and no indication the product contributed to the infection.Infections are anticipated when performing craniotomy procedures.(b)(4) 2015 neuropace, inc.Reevaluated this record.Based on internal review of the fda regulations, guidance document (draft guidance for industry and food and drug administration staff), and internal procedures, neuropace, inc.Determined that complaints associated with incision site infections are reportable.These past events show no indication that the product caused the infection and there is no indication of product failure.The rns system remains implanted and is programmed for detection and therapy.Sterility record review performed.No evidence of factors that could have caused or contributed to the reported event.All sterilization results met requirements as specified in the specifications.Product remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key4954153
MDR Text Key6039023
Report Number3004426659-2015-00019
Device Sequence Number1
Product Code PFN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberRNS NEUROSTIMULATOR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/19/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age46 YR
-
-